医学
抗风湿药物
不利影响
药品
甲氨蝶呤
安全概况
重症监护医学
抗风湿药
贾纳斯激酶
疾病
药理学
内科学
细胞因子
作者
Johanna Mücke,Hans‐Uwe Simon,Gerd R Burmester
出处
期刊:PubMed
日期:2022-11-02
卷期号: (Forthcoming)
被引量:8
标识
DOI:10.3238/arztebl.m2021.0389
摘要
Drug therapy for rheumatic diseases has changed fundamentally in recent decades with the introduction of many new agents. As these drugs may have to be taken for many years, and many of them are of similar efficacy, their safety profiles play an important role in therapeutic decisionmaking.
科研通智能强力驱动
Strongly Powered by AbleSci AI